180 related articles for article (PubMed ID: 37534527)
1. Phenotypic profiling of CD34
Bugarin C; Antolini L; Buracchi C; Matarraz S; Coliva TA; Van der Velden VH; Szczepanski T; Da Costa ES; Van der Sluijs A; Novakova M; Mejstrikova E; Nierkens S; De Mello FV; Fernandez P; Aanei C; Sędek Ł; Strocchio L; Masetti R; Sainati L; Philippé J; Valsecchi MG; Locatelli F; Van Dongen JJM; Biondi A; Orfao A; Gaipa G
Haematologica; 2024 Feb; 109(2):521-532. PubMed ID: 37534527
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic characteristics of juvenile myelomonocytic leukaemia and their relation with the molecular subgroups of the disease.
Frisanco Oliveira A; Tansini A; Toledo TR; Balceiro R; Onofre Vidal D; de Martino Lee ML; Lorand-Metze I; Lopes LF
Br J Haematol; 2021 Jan; 192(1):129-136. PubMed ID: 32966606
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia.
Oliveira AF; Tansini A; Vidal DO; Lopes LF; Metze K; Lorand-Metze I
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27748021
[TBL] [Abstract][Full Text] [Related]
4. Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34(+) cells of juvenile myelomonocytic leukemia.
Nakazawa Y; Matsuda K; Kurata T; Sueki A; Tanaka M; Sakashita K; Imai C; Wilson MH; Koike K
J Hematol Oncol; 2016 Mar; 9():27. PubMed ID: 26983639
[TBL] [Abstract][Full Text] [Related]
5. In vitro expansion of CD34(+)CD38(-) cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia.
Sakashita K; Kato I; Daifu T; Saida S; Hiramatsu H; Nishinaka Y; Ebihara Y; Ma F; Matsuda K; Saito S; Hirabayashi K; Kurata T; Uyen LT; Nakazawa Y; Tsuji K; Heike T; Nakahata T; Koike K
Leukemia; 2015 Mar; 29(3):606-14. PubMed ID: 25102944
[TBL] [Abstract][Full Text] [Related]
6. Panobinostat inhibits the proliferation of CD34
Kurata T; Matsuda K; Hirabayashi K; Shigemura T; Sakashita K; Nakahata T; Koike K
Pediatr Blood Cancer; 2018 Nov; 65(11):e27261. PubMed ID: 30014555
[TBL] [Abstract][Full Text] [Related]
7. Functional evaluation of circulating hematopoietic progenitors in Noonan syndrome.
Timeus F; Crescenzio N; Baldassarre G; Doria A; Vallero S; Foglia L; Pagliano S; Rossi C; Silengo MC; Ramenghi U; Fagioli F; Cordero di Montezemolo L; Ferrero GB
Oncol Rep; 2013 Aug; 30(2):553-9. PubMed ID: 23756559
[TBL] [Abstract][Full Text] [Related]
8. Wiskott-Aldrich syndrome presenting with a clinical picture mimicking juvenile myelomonocytic leukaemia.
Yoshimi A; Kamachi Y; Imai K; Watanabe N; Nakadate H; Kanazawa T; Ozono S; Kobayashi R; Yoshida M; Kobayashi C; Hama A; Muramatsu H; Sasahara Y; Jakob M; Morio T; Ehl S; Manabe A; Niemeyer C; Kojima S
Pediatr Blood Cancer; 2013 May; 60(5):836-41. PubMed ID: 23023736
[TBL] [Abstract][Full Text] [Related]
9. [Juvenile myelomonocytic leukemias].
Lachenaud J; Strullu M; Baruchel A; Cavé H
Bull Cancer; 2014 Mar; 101(3):302-13. PubMed ID: 24691193
[TBL] [Abstract][Full Text] [Related]
10. Nonsyndromic Juvenile Myelomonocytic Leukemia With PTPN11 Mutation in a 9-Year-old Girl.
Sarper N; Gelen SA; Zengin E; Demirsoy U; Erçin C
J Pediatr Hematol Oncol; 2015 Aug; 37(6):486-7. PubMed ID: 26181421
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features and prognosis of juvenile myelomonocytic leukemia: an analysis of 63 cases].
Yang WY; Liu LP; Liu F; Qi BQ; Chang LX; Zhang L; Chen XJ; Zou Y; Chen YM; Guo Y; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):265-271. PubMed ID: 36946161
[TBL] [Abstract][Full Text] [Related]
12. Mutational landscape of Juvenile Myelomonocytic Leukemia (JMML)-A real-world context.
Nathany S; Chatterjee G; Ghai S; Moulik NR; Shetty D; Subramanian PG; Tembhare P; Gujral S; Dhamne C; Banavali S; Narula G; Patkar N
Int J Lab Hematol; 2021 Dec; 43(6):1531-1538. PubMed ID: 34387930
[TBL] [Abstract][Full Text] [Related]
13. Aberrant phosphorylation of STAT5 by granulocyte-macrophage colony-stimulating factor in infant cytomegalovirus infection mimicking juvenile myelomonocytic leukemia.
Nishio N; Takahashi Y; Tanaka M; Xu Y; Yoshida N; Sakaguchi H; Doisaki S; Hama A; Muramatsu H; Shimada A; Kojima S
Leuk Res; 2011 Sep; 35(9):1261-4. PubMed ID: 21571368
[TBL] [Abstract][Full Text] [Related]
14. KMT2A-rearranged infantile acute myeloid leukemia masquerading as juvenile myelomonocytic leukemia.
Kanayama T; Imamura T; Kawabe Y; Osone S; Tahara J; Iwasaki F; Miyagawa N; Goto H; Imashuku S; Hosoi H
Int J Hematol; 2018 Dec; 108(6):665-669. PubMed ID: 30143999
[TBL] [Abstract][Full Text] [Related]
15. EVI-1 gene expression in myeloid clonogenic cells from juvenile myelomonocytic leukemia (JMML).
Privitera E; Longoni D; Brambillasca F; Biondi A
Leukemia; 1997 Dec; 11(12):2045-8. PubMed ID: 9447818
[TBL] [Abstract][Full Text] [Related]
16. Lineage-dependent skewing of loss of heterozygosity (LOH) of KRAS gene in a case of juvenile myelomonocytic leukemia.
Tokuda K; Eguchi-Ishimae M; Iwabuki H; Kawakami S; Tauchi H; Ishii E; Eguchi M
Eur J Haematol; 2015 Feb; 94(2):177-81. PubMed ID: 24766281
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and laboratory characteristics of juvenile myelomonocytic leukemia].
Wu YY; Cai SY; Huang W; Li SS; Li W; Dong A
Zhongguo Dang Dai Er Ke Za Zhi; 2018 May; 20(5):373-377. PubMed ID: 29764573
[TBL] [Abstract][Full Text] [Related]
18. Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia.
Hasegawa D; Bugarin C; Giordan M; Bresolin S; Longoni D; Micalizzi C; Ramenghi U; Bertaina A; Basso G; Locatelli F; Biondi A; Te Kronnie G; Gaipa G
Blood Cancer J; 2013 Nov; 3(11):e160. PubMed ID: 24241400
[TBL] [Abstract][Full Text] [Related]
19. Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.
Yoshimi A; Balasis ME; Vedder A; Feldman K; Ma Y; Zhang H; Lee SC; Letson C; Niyongere S; Lu SX; Ball M; Taylor J; Zhang Q; Zhao Y; Youssef S; Chung YR; Zhang XJ; Durham BH; Yang W; List AF; Loh ML; Klimek V; Berger MF; Stieglitz E; Padron E; Abdel-Wahab O
Blood; 2017 Jul; 130(4):397-407. PubMed ID: 28576879
[TBL] [Abstract][Full Text] [Related]
20. Role of lncRNA Morrbid in PTPN11(Shp2)E76K-driven juvenile myelomonocytic leukemia.
Cai Z; Zhang C; Kotzin JJ; Williams A; Henao-Mejia J; Kapur R
Blood Adv; 2020 Jul; 4(14):3246-3251. PubMed ID: 32697817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]